Market Cap

ValiRx plc Market Capitalization:

£3.5 Million

GBP as of July 1, 2024

US$4.4 Million

business ValiRx plc Company Profile

ValiRx plc Main Stock Listing

LSE: VAL

Market Capitalization History of ValiRx plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of ValiRx plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £6.3 M -51.22%
Jan. 1, 2023 £12.8 M -64.04%
Jan. 1, 2022 £35.7 M 22.58%
Jan. 1, 2021 £29.1 M 124.10%
Jan. 1, 2020 £13.0 M -90.24%
Jan. 1, 2019 £133.1 M -74.81%
Jan. 1, 2018 £528.4 M -27.03%
Jan. 1, 2017 £724.2 M -71.97%
Jan. 1, 2016 £2.58 B -42.61%
Jan. 1, 2015 £4.50 B -35.21%
Jan. 1, 2014 £6.95 B -24.47%
Jan. 1, 2013 £9.20 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

ValiRx plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

ValiRx plc has the following listings and related stock indices.


Stock: LSE: VAL

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.